Equity Profile
Pre-Earnings Brief
COMPANHIA DE SANEAME ADR operates in the utilities sector, specifically focusing on water utilities. As a major player in providing essential water services, the company plays a crucial role in public health and infrastructure, making it significant for both consumers and investors.
EPS
Earnings per share (EPS) is a key indicator of profitability and financial health, and investors will look for any surprises compared to expectations.
Revenue
Revenue figures provide insight into the company's sales performance and growth potential, which is critical for assessing overall business health.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
0Q
EPS Beat Rate
25%
Avg EPS Surprise
+30.05%
Avg Stock Reaction
-2.74%
In the last quarter, SBS reported an EPS of $0.85, exceeding expectations, but the stock fell by 5.51% the following day. This decline suggests that while earnings were strong, market sentiment may have been influenced by other factors.
Management Promises & Guidance
Analysts are generally expecting SBS to report steady earnings this quarter, with a consensus EPS of $0.42. The market is keen to see if the company can maintain its profitability amidst potential challenges.
Bull Case
If SBS beats the EPS estimate, it could signal strong operational efficiency and growth, potentially boosting investor confidence and stock price.
Bear Case
Conversely, if the company misses expectations, it may raise concerns about its ability to sustain profitability, leading to a negative reaction in the stock.
EPS
$0.42Earnings per share (EPS) is a key indicator of profitability and financial health, and investors will look for any surprises compared to expectations.
Revenue
$6.4BRevenue figures provide insight into the company's sales performance and growth potential, which is critical for assessing overall business health.
Expectations
The print will turn on these two things.
Q1
Will SBS achieve an EPS of $0.42 or higher?
This specific EPS target is crucial for investor confidence and could impact stock performance significantly.
Q2
What factors influenced revenue growth this quarter?
Understanding revenue drivers will help assess the company's operational health and future outlook.
Edge
Why consensus could be wrong
The Street may be underestimating the potential for SBS to exceed EPS expectations based on past performance and operational improvements.
Supporting Evidence
SBS has consistently beaten EPS estimates in the past, suggesting a strong operational track record.
The options market is pricing a significant move, indicating that investors expect volatility which could favor a positive surprise.
Key Risk
If the EPS comes in below $0.40, it could invalidate the positive outlook and lead to a reassessment of the company's growth potential.
Edge
Pre-commit to what would confirm each case.
This quarter's performance is critical as it will indicate whether SBS can maintain its profitability amidst market pressures.
Bull Confirmed If
An EPS of $0.45 or higher would confirm strong operational performance and growth potential.
Bear Confirmed If
An EPS below $0.40 would raise concerns about profitability and operational challenges.
Pre-Earnings Positioning
Implied Move
±19.34%
Historical Avg
±4.1%
The options market is pricing in a significant potential move, indicating that investors are anticipating volatility around the earnings report.
Options are pricing ±19.3% while SBS has averaged ±4.1% over the last 8 prints — setup is pricing rich.
30d HV
37.4%
Edge
Smart-money positioning from the most recent 13F filings.
Institutional
10.88%
of float
Insider
15.00%
of float
Holders
335
institutions
Top Holders· as of Dec 2025
Impax Asset Management Group plc
7,463,013 sh · $259.0M
1.06%
-11.8%
Blackrock Inc.
6,176,152 sh · $214.3M
0.88%
70.9%
Amundi
5,527,444 sh · $191.8M
0.78%
-1.8%
Deutsche Bank AG
3,960,177 sh · $137.4M
0.56%
-36.8%
Manning & Napier Advisors LLC
2,891,186 sh · $100.3M
0.41%
-9.3%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If SBS beats expectations, history suggests the stock could rise by around 4.14%, confirming a positive outlook.
In-Line / Cautious
If results are in line with expectations, the stock may see muted movement as investors await further commentary.
Miss
A miss could lead to a decline, with historical patterns suggesting an average drop of around 1.12%.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AXSOME THERAPEUTICS